The Efficacy of Risk Factor Modification Compared to NAD+ Repletion in Diastolic Heart Failure
2024 · JACC Basic to Translational Science · 16 citations
https://doi.org/10.1016/j.jacbts.2024.01.011
Broad Institute(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
44
Citations
3
h-index
2
i10-index
Niv Vigder is an academic researcher from Broad Institute. The author has contributed to research in topics: Cardiovascular Function and Risk Factors & Heme Oxygenase-1 and Carbon Monoxide & Neonatal Health and Biochemistry. The author has an h-index of 3, co-authored 12 publications.
ORCID: 0009-0004-9693-4779https://doi.org/10.1016/j.jacbts.2024.01.011
https://doi.org/10.1038/s41536-025-00433-y
Click to start Chat